ESMO 2012 Press Release: Many cancer patients unaware of the personalised medicine revolution in oncology, survey shows
811 people surveyed by Prof Tejpar and colleagues
Phase III data in treatment of renal cell carcinoma reported
New trial results on pazopanib and temsirolimus have important implications for patients
First large scale trial of whole-genome cancer testing for clinical decision-making reported
Study opens a new door to more personalised treatment of advanced breast cancer
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer
Head-to-head study compares of crizotinib with standard chemotherapy in this patient group
ESMO 2012 Press Release: Myths and misunderstandings hamper efforts to prevent cancer
Studies presented at ESMO 2012 highlight challenges of cancer prevention
ESMO Congresses in Vienna - what stories previously made a buzz
Take a stroll down memory lane and check out the `hot´ topics from past ESMO congresses in Vienna
Governments failing to address “global pandemic of untreated cancer pain”
Landmark global survey reveals major shortcomings in many countries around the world
Studies show drug combinations effective for melanoma
Promising new data from trials aimed at delaying resistance to BRAF inhibitors